Is Ultragenyx Pharmaceutical Inc. (RARE) a Buy, Sell, or Hold?
NASDAQ : RARE
Ultragenyx Pharmaceutical Inc.
$30.22 USD
-$1.49 (-4.7%)
- Volume
- 1.8M
- Average Volume
- 2.16M
- Market Capitalization
- $2.98B
- P/E Ratio
- -4.95
- Dividend Yield
- 0.00%
- Price Target
- $43.00
- Year High
- $39.89
- Year Low
- $18.29
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.02
CCURRENT INSTITUTIONAL OWNERSHIP PERCENTAGE
0.38%
Investors Holding
18
change: -293 | last: 311
Increased Positions
11
change: -175 | last: 186
Reduced Positions
4
change: -80 | last: 84
New Positions
4
change: -54 | last: 58
Sold Positions
281
change: 223 | last: 58
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -71.6392 | last: 0.7164
Total Invested
12.77M
RARE Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $23.00 | 98.6M | $2.27B | $434M | $1.28B | $3.11B |
| 2024-12-31 | $42.07 | 90.54M | $3.81B | $173.73M | $40.34M | $3.68B |
| 2023-12-31 | $47.82 | 73.54M | $3.52B | $213.58M | $43.17M | $3.35B |
| 2022-12-31 | $46.33 | 69.91M | $3.24B | $132.94M | $31.59M | $3.14B |
| 2021-12-31 | $84.09 | 67.8M | $5.7B | $307.58M | $41.97M | $5.44B |
| 2020-12-31 | $138.43 | 60.85M | $8.42B | $713.53M | $48.23M | $7.76B |
| 2019-12-31 | $42.71 | 56.58M | $2.42B | $433.58M | $36.99M | $2.02B |
| 2018-12-31 | $43.48 | 49.78M | $2.16B | $113.43M | -$ | $2.05B |
| 2017-12-31 | $46.38 | 42.45M | $1.97B | $100.49M | -$ | $1.87B |
| 2016-12-31 | $70.31 | 39.59M | $2.78B | $161.12M | -$ | $2.62B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20.95 | 100.6M | $2.11B | $175M | $1.2B | $3.13B |
| 2025-12-31 | $23.00 | 99.9M | $2.3B | $434M | $1.28B | $3.14B |
| 2025-09-30 | $30.08 | 99.77M | $3B | $212.34M | $884.8M | $3.67B |
| 2025-06-30 | $36.36 | 98.46M | $3.58B | $166.11M | $36.3M | $3.45B |
| 2025-03-31 | $36.21 | 96.29M | $3.49B | $127.06M | $38.27M | $3.4B |
| 2024-12-31 | $42.07 | 95.68M | $4.03B | $173.73M | $40.34M | $3.89B |
| 2024-09-30 | $55.55 | 95.49M | $5.3B | $150.62M | $34.08M | $5.19B |
| 2024-06-30 | $41.12 | 86.58M | $3.56B | $480.69M | $37.46M | $3.12B |
| 2024-03-31 | $46.97 | 84.29M | $3.96B | $112.25M | $40.76M | $3.89B |
| 2023-12-31 | $47.82 | 81.12M | $3.88B | $213.58M | $43.17M | $3.71B |
| 2023-09-30 | $35.65 | 71.66M | $2.55B | $72.58M | $46.62M | $2.53B |
| 2023-06-30 | $46.13 | 70.9M | $3.27B | $102.06M | $25.73M | $3.19B |